The 21st Century Cures Act, COVID-19, and the pending real world data guidance slated for later in 2021, have brightened the spotlight on the power of real world data (RWD) and real world evidence (RWE). RWE continues to be at the forefront in providing value in regulatory science and innovation when it comes to new data, methods, and tools. How do you leverage RWE in a manner that is fit-for-purpose, to support a regulatory submission?

During this webinar, hear from IQVIA leader Dr. Marni Hall, former Director, Regulatory Science Office of Surveillance and Epidemiology at the FDA, and current Vice President for Clinical Evidence and Head of U.S. Regulatory Science and Strategy at IQVIA, on the use of RWE for regulatory decision-making.

IQVIA speaker, Dr. Marni Hall will discuss the importance of regulatory science as regulators innovate, and the critical role the industry plays in helping to shape the future use of RWE. The presentation will introduce RWD and RWE, discuss innovative approaches and processes you can take back to your organization to foster use of RWE, and highlight success stories in leveraging RWE to support regulatory approvals. You don’t always know how useful your data can be, the insights you can glean, and the opportunity it presents, until that data is looked at through another lens.

Click here for additional information and registration details.


Related Content

Evidence Matters 2022

Evidence Matters 2022

Evidence Matters is a virtual one-day summit that brings the literature review community together from different industries to learn, engage, and solve ever-pressing evidence-based research challenges.